Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3',4',7-trihydroxyethylrutin
2. 3',4',7-tris(o-(2- Hydroxyethyl))rutin
3. Oxerutin
4. Paroven
5. Posorutin
6. Relvene
7. Rhoflux
8. Teboven
9. Troxrutine Mazal
10. Troxerutin-ratiopharm
11. Troxeven
12. Vastribil
13. Veinamitol
14. Veniten Retard
15. Veno Sl
16. Venorutin
17. Venoruton
18. Venoruton P4
19. Venotrulan Trox
20. Vitamin P4
1. 7085-55-4
2. Posorutin
3. Troxerutine
4. Vitamin P4
5. Venoruton P4
6. Trioxyethylrutin
7. Trihydroxyethylrutin
8. 3',4',7-tris(hydroxyethyl)rutin
9. Factor P-zyma
10. Rufen-p4
11. Tris(hydroxyethyl)rutin
12. Tris(hydroxyethyl)rutoside
13. Troxerutin (inn)
14. Z 6000
15. 7y4n11pxo8
16. Nsc-758937
17. Pherarutin
18. Vastribil
19. Veinamitol
20. Troxerutin [inn]
21. Z-6000
22. Veno Sl
23. 2-(3,4-bis(2-hydroxyethoxy)phenyl)-5-hydroxy-7-(2-hydroxyethoxy)-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
24. Troksevazin
25. Troxarutin
26. Troxerutina
27. Troxerutinum
28. Helveton
29. Venaroid
30. Veniten
31. Flebil
32. Ruven
33. 3,5-dihydroxy-3',4',7-tris(2-hydroxyethoxy)flavone 3-rutinoside
34. Pur-rutin
35. Veinamitol Pulver
36. 4h-1-benzopyran-4-one, 2-[3,4-bis(2-hydroxyethoxy)phenyl]-3-[[6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl]oxy]-5-hydroxy-7-(2-hydroxyethoxy)-
37. Troxarutin-ratiopharm
38. Trihydroxyethylrutoside
39. Troxerutine [inn-french]
40. Troxerutinum [inn-latin]
41. Troxerutina [inn-spanish]
42. Unii-7y4n11pxo8
43. Troxerutin [inn:ban:dcf]
44. Venoruton Gel
45. Ccris 1798
46. Trihydroxyethylrutoside [french]
47. Triher
48. Troxerutin,(s)
49. Ncgc00095147-01
50. 2-(3,4-bis(2-hydroxyethoxy)phenyl)-5-hydroxy-7-(2-hydroxyethoxy)-3-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)methyl)tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
51. 4h-1-benzopyran-4-one, 2-(3,4-bis(2-hydroxyethoxy)phenyl)-3-((6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl)oxy)-5-hydroxy-7-(2-hydroxyethoxy)-
52. Einecs 230-389-4
53. Troxerutin (85%)
54. Brn 4778232
55. 7,3',4'-tris(o-(2-hydroxyethyl)rutin
56. Troxerutin [mi]
57. Troxerutin [inci]
58. Troxerutin [mart.]
59. Dsstox_cid_25929
60. Dsstox_rid_81230
61. Troxerutin [who-dd]
62. Dsstox_gsid_45929
63. Schembl142110
64. Tris-o-(2-hydroxyethyl)rutin
65. Chembl3182320
66. Dtxsid4045929
67. Tris-o-(b-hydroxyethyl)rutoside
68. Unii-808o347b5y
69. Troxerutin [ep Monograph]
70. Hy-n0139
71. Tox21_111450
72. Mfcd00893813
73. S2369
74. Zinc85552699
75. Akos016339659
76. Succinimidyln-methylanthranilate
77. Trihydroxyethylrutin, >=80% (hplc)
78. 808o347b5y
79. Ccg-270428
80. Cs-8204
81. Db13124
82. Ks-1394
83. Nsc 758937
84. 2-(3,4-bis(2-hydroxyethoxy)phenyl)-3-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-5-hydroxy-7-(2-hydroxy Ethoxy)-4h-1-benzopyran-4-one
85. 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
86. 3',4',7-tri-o-(b-hydroxyethyl)rutoside
87. Cas-7085-55-4
88. O-(beta-hydroxyethyl)-tutinosides (mixture)
89. 3,4,7-tris-o-(2-hydroxyethyl)rutin
90. D07180
91. 085t554
92. A837010
93. Brd-k73529671-001-04-5
94. O-(.beta.-hydroxyethyl)rutoside, (3',4',7)-tri-
95. Troxerutin, European Pharmacopoeia (ep) Reference Standard
96. 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-3-[[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-2-oxanyl]oxymethyl]-2-oxanyl]oxy]-1-benzopyran-4-one
97. 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4h-chromen-4-one
98. 2-[3,4-bis(2-hydroxyethyloxy)phenyl]-7-(2-hydroxyethyloxy)-3-[(2s,3r,4s,5s,6r)-6-[[(2r,3r,4r,5r,6s)-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-oxidanyl-chromen-4-one
99. 3-[6-o-(6-deoxy-a-l-mannopyranosyl)-b-d-glucopyranoside]3,5-dihydroxy-3',4',7-tris(2-hydroxyethoxy)-flavone
100. 3-[6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-delta-glucopyranoside]3,5-dihydroxy-3',4',7-tris(2-hydroxyethoxy)-flavone
101. 4h-1-benzopyran-4-one,2-[3,4-bis(2-hydroxyethoxy)phenyl]-3-[[6-o-(6-deoxy-a-l-mannopyranosyl)-b-d-glucopyranosyl]oxy]-5-hydroxy-7-(2-hydroxyethoxy)-
102. 55965-63-4
103. Flavone, 3,5-dihydroxy-3',4',7-tris(2-hydroxyethoxy)-, 3-(6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside)
Molecular Weight | 742.7 g/mol |
---|---|
Molecular Formula | C33H42O19 |
XLogP3 | -2.4 |
Hydrogen Bond Donor Count | 10 |
Hydrogen Bond Acceptor Count | 19 |
Rotatable Bond Count | 15 |
Exact Mass | 742.23202911 g/mol |
Monoisotopic Mass | 742.23202911 g/mol |
Topological Polar Surface Area | 293 Ų |
Heavy Atom Count | 52 |
Formal Charge | 0 |
Complexity | 1170 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anticoagulants
Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)
C05CA04
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
C - Cardiovascular system
C05 - Vasoprotectives
C05C - Capillary stabilizing agents
C05CA - Bioflavonoids
C05CA04 - Troxerutin
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Troxerutin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Troxerutin, including repackagers and relabelers. The FDA regulates Troxerutin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Troxerutin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Troxerutin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Troxerutin supplier is an individual or a company that provides Troxerutin active pharmaceutical ingredient (API) or Troxerutin finished formulations upon request. The Troxerutin suppliers may include Troxerutin API manufacturers, exporters, distributors and traders.
click here to find a list of Troxerutin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Troxerutin DMF (Drug Master File) is a document detailing the whole manufacturing process of Troxerutin active pharmaceutical ingredient (API) in detail. Different forms of Troxerutin DMFs exist exist since differing nations have different regulations, such as Troxerutin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Troxerutin DMF submitted to regulatory agencies in the US is known as a USDMF. Troxerutin USDMF includes data on Troxerutin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Troxerutin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Troxerutin suppliers with USDMF on PharmaCompass.
A Troxerutin CEP of the European Pharmacopoeia monograph is often referred to as a Troxerutin Certificate of Suitability (COS). The purpose of a Troxerutin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Troxerutin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Troxerutin to their clients by showing that a Troxerutin CEP has been issued for it. The manufacturer submits a Troxerutin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Troxerutin CEP holder for the record. Additionally, the data presented in the Troxerutin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Troxerutin DMF.
A Troxerutin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Troxerutin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Troxerutin suppliers with CEP (COS) on PharmaCompass.
Troxerutin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Troxerutin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Troxerutin GMP manufacturer or Troxerutin GMP API supplier for your needs.
A Troxerutin CoA (Certificate of Analysis) is a formal document that attests to Troxerutin's compliance with Troxerutin specifications and serves as a tool for batch-level quality control.
Troxerutin CoA mostly includes findings from lab analyses of a specific batch. For each Troxerutin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Troxerutin may be tested according to a variety of international standards, such as European Pharmacopoeia (Troxerutin EP), Troxerutin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Troxerutin USP).
LOOKING FOR A SUPPLIER?